These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 2121017)

  • 21. Efficacy and safety of combination therapy with amiodarone and type I agents for treatment of inducible ventricular tachycardia.
    Jung W; Mletzko R; Manz M; Nitsch J; Lüderitz B
    Pacing Clin Electrophysiol; 1993 Apr; 16(4 Pt 1):778-88. PubMed ID: 7683805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Demonstration of proarrhythmic activity with the class IC antiarrhythmic agent encainide in a canine model of previous myocardial infarction.
    Wallace AA; Stupienski RF; Kothstein T; Gehret JR; Lynch JJ
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):397-404. PubMed ID: 7681500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of electrophysiological testing and long-term follow-up in patients sustaining cardiac arrest only while receiving type IA antiarrhythmic agents.
    Hook BG; Rosenthal ME; Marchlinski FE; Buxton AE; Josephson ME
    Pacing Clin Electrophysiol; 1992 Mar; 15(3):324-33. PubMed ID: 1372727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Encainide and flecainide: are they interchangeable?
    Saini V; Podrid PJ; Slater W; Lown B
    Am Heart J; 1989 Jun; 117(6):1253-8. PubMed ID: 2499169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
    Abdollah H; Brugada P; Green M; Wehr M; Wellens HJ
    Am J Cardiol; 1984 Sep; 54(6):544-9. PubMed ID: 6433688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of inducible sustained ventricular tachyarrhythmias in patients with coronary artery disease.
    Vorperian VR; Gittelsohn AM; Veltri EP
    J Am Coll Cardiol; 1989 Mar; 13(3):637-45. PubMed ID: 2918170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproducibility of electrophysiologic testing during antiarrhythmic therapy for ventricular arrhythmias secondary to coronary artery disease.
    Ferrick KJ; Luce J; Miller S; Mercando AD; Kim SG; Roth JA; Fisher JD
    Am J Cardiol; 1992 May; 69(16):1296-9. PubMed ID: 1585863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic and electrophysiologic effects of encainide in patients with bundle branch block.
    Schwartz AB; Shapiro WA; Suave MJ; Shen E; Bhandari A; Morady F; Scheinman M
    Can J Cardiol; 1987 Mar; 3(2):75-82. PubMed ID: 3105850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias.
    Morganroth J; Somberg JC; Pool PE; Hsu PH; Lee IK; Durkee J; Salerno DM
    J Am Coll Cardiol; 1986 Jan; 7(1):9-16. PubMed ID: 3079781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-response range of encainide for benign and potentially lethal ventricular arrhythmias.
    Morganroth J; Pool P; Miller R; Hsu PH; Lee I; Clark DM
    Am J Cardiol; 1986 Apr; 57(10):769-74. PubMed ID: 3083665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of the electrophysiology laboratory for evaluation of proarrhythmic drug response in coronary artery disease.
    Buxton AE; Rosenthal ME; Marchlinski FE; Miller JM; Flores B; Josephson ME
    Am J Cardiol; 1991 Apr; 67(9):835-42. PubMed ID: 1707220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute effects of combination of IB and IC antiarrhythmics for the treatment of ventricular tachycardia.
    Bleske BE; Kluger J; Fisher J; Chow MS
    J Clin Pharmacol; 1989 Nov; 29(11):998-1002. PubMed ID: 2513339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of programmed stimulation methods in the evaluation of ventricular arrhythmias in patients 20 years old and younger.
    Silka MJ; Kron J; Cutler JE; McAnulty JH
    Am J Cardiol; 1990 Oct; 66(10):826-30. PubMed ID: 2220580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiology in assessing supraventricular arrhythmias: value of programmed stimulation in predicting and understanding efficacy of encainide.
    Wellens HJ; Brugada P
    Am J Cardiol; 1986 Aug; 58(5):37C-40C. PubMed ID: 3092617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of ibutilide on spontaneous and induced ventricular arrhythmias in 24-hour canine myocardial infarction: a comparative study with sotalol and encainide.
    Buchanan LV; Kabell G; Turcotte UM; Brunden MN; Gibson JK
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):256-63. PubMed ID: 1376795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proarrhythmic effects of antiarrhythmic drugs in patients with malignant ventricular arrhythmias evaluated by electrophysiologic testing.
    Rae AP; Kay HR; Horowitz LN; Spielman SR; Greenspan AM
    J Am Coll Cardiol; 1988 Jul; 12(1):131-9. PubMed ID: 3379198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone.
    Manolis AS; Uricchio F; Estes NA
    Am J Cardiol; 1989 May; 63(15):1052-7. PubMed ID: 2705375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic effects of encainide in patients with ventricular arrhythmia and poor ventricular function.
    Sami MH; Derbekyan VA; Lisbona R
    Am J Cardiol; 1983 Sep; 52(5):507-11. PubMed ID: 6412535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrophysiology of oral encainide.
    Jackman WM; Zipes DP; Naccarelli GV; Rinkenberger RL; Heger JJ; Prystowsky EN
    Am J Cardiol; 1982 Apr; 49(5):1270-8. PubMed ID: 6801954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts.
    Kuchar DL; Garan H; Venditti FJ; Finkelstein D; Rottman JN; McComb J; McGovern BA; Ruskin JN
    Am J Cardiol; 1989 Jul; 64(1):33-6. PubMed ID: 2741811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.